(250 days)
Not Found
No
The device description and performance studies focus on the physical and biological properties of the topical emulsions, with no mention of AI or ML technologies.
Yes
The devices are indicated for treating wounds, burns, and other skin injuries, which are therapeutic uses.
No
Explanation: The provided text describes topical emulsions used for wound dressing and skin treatment (burns, abrasions, ulcers), not for diagnosing conditions. Their function is therapeutic, not diagnostic.
No
The device description clearly states it is a topical emulsion consisting of water, wax, and dissolved ingredients, which are physical substances, not software.
Based on the provided information, none of these devices are IVDs (In Vitro Diagnostics).
Here's why:
- IVDs are used to examine specimens from the human body. The intended use and device descriptions clearly indicate that these products are topical emulsions applied directly to the skin for wound care. They are not used to analyze blood, urine, tissue, or any other bodily fluid or sample.
- The intended uses are for treating wounds and skin conditions. This is a therapeutic application, not a diagnostic one.
The information provided describes wound dressings, which are medical devices, but they fall under a different regulatory category than IVDs.
N/A
Intended Use / Indications for Use
HYDROPERMEATE™ Topical Emulsion is indicated for use in: Full thickness wounds, pressure sores, dermal ulcers including lower leg ulcers Superficial wounds 1st and 2nd degree burns, including sunburns Dermal donor and graft site management Radiation dermatitis Minor abrasions.
ANSWER2SKIN™ SUNBURN RELIEF Cream is intended to be used Over-the-Counter as a wound dressing for the following indications: minor burns, including minor sunburns.
ANSWER2SKIN™ FIRST AID Cream is intended to be used Over-the-Counter as a wound dressing for the following indications: minor superficial wounds and minor abrasions, including cuts and scrapes.
Product codes (comma separated list FDA assigned to the subject device)
FRO
Device Description
HYDROPERMEATE™ Topical Emulsion consists of approximately 75% purified water, 20% wax (oily) ingredients, and 5% of dissolved ingredients such as triethanolamine sodium alginate, which forms a gel with water. HYDROPERMEATE™ is a prescription product.
ANSWER2SKIN™ SUNBURN RELIEF Cream, and ANSWER2SKIN™ FIRST AID Cream are topical emulsions consisting of approximately 75% purified water, 20% wax (oily) ingredients, and 5% of dissolved ingredients such as triethanolamine sodium alginate, which forms a gel with water. ANSWER2SKIN™ SUNBURN RELIEF Cream, and ANSWER2SKIN™ FIRST AID Cream are over-the-counter products.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Prescription Use (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C)
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The Dermal Life product was tested for performance criteria (physical parameters, biocompatibility, human dermal studies for irritation and dermal sensitization). Performance data support that the Dermal Life wound dressing meets its specified criteria. Functional and performance testing has been conducted to assess the safety and efficacy of HYDROPERMEATE™ Topical Emulsion and the results support the substantial equivalence to the predicate device.
The Dermal Life products were tested for performance criteria (physical parameters, biocompatibility, human dermal studies for irritation and dermal sensitization). Performance data support that the Dermal Life wound dressings meet its specified criteria. Functional and performance testing has been conducted to assess the safety and efficacy of ANSWER2SKIN™ SUNBURN RELIEF Cream, and ANSWER2SKIN™ FIRST AID Cream and the results support the substantial equivalence to the predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
N/A
0
DERMAL LIFE
Advanced Skin Care Solutions
510(k) Summary of Safety and Effectiveness
MAY 01 2013
HYDROPERMEATE™ Topical Emulsion
Manufacturer and Submitter
| Company Name: | Dermal Life LLC |
|---|---|
| Company Address: | 13046 Race Track Rd. |
| Tampa, FL 33636 | |
| Telephone: | 317.669.2229 |
| Contact Person: | William R. Hitchens |
| Date Summary Prepared: | August 24, 2012 |
Device
Trade/Device Name: Common/Usual Name: Classification Name: Regulation Number: Product Code: Classification Panel: Classification:
Dressing, Wound, Drug Wound Dressing Containing Drug Unclassified Unclassified FRO General & Plastic Surgery Unclassified
Substantial Equivalence
This 510(k) submission demonstrates that HYDROPERMEATE™ Topical Emulsion is substantially equivalent to BIAFINE™ Wound Dressing Emulsion (K964240) in both technology and intended use.
Device Description
HYDROPERMEATE™ Topical Emulsion consists of approximately 75% purified water, 20% wax (oily) ingredients, and 5% of dissolved ingredients such as triethanolamine sodium alginate, which forms a gel with water. HYDROPERMEATE™ is a prescription product.
Indications for Use
The prescription product requires a physician's diagnosis and is indicated as follows:
HYDROPERMEATE™ Topical Emulsion is indicated for use in:
- Full thickness wounds, pressure sores, dermal ulcers including lower leg ulcers 트
- 트 Superficial wounds
- 트 1st and 2nd degree burns, including sunburns
- D Dermal donor and graft site management
- D Radiation dermatitis
- I Minor abrasions
1
Image /page/1/Picture/0 description: The image shows a handwritten string of alphanumeric characters. The string appears to be "K122595". The characters are written in black ink on a white background. The handwriting is somewhat messy, but the characters are still legible.
Image /page/1/Picture/1 description: The image shows the logo for Dermal Life Advanced Skin Care Solutions. The logo features the text "DERMAL LIFE" in a bold, sans-serif font. Below the main text, there is the tagline "Advanced Skin Care Solutions" in a smaller font. There is a graphic to the left of the text that looks like a stylized sun or star.
Summary of Technological Characteristics of the Device Compared to Predicate Device
HYDROPERMEATE™ Topical Emulsion is technologically similar to the predicate device. The Dermal Life product was tested for performance criteria (physical parameters, biocompatibility, human dermal studies for irritation and dermal sensitization). Performance data support that the Dermal Life wound dressing meets its specified criteria.
Conclusion
Functional and performance testing has been conducted to assess the safety and efficacy of HYDROPERMEATE™ Topical Emulsion and the results support the substantial equivalence to the predicate device.
2
DERMAL LIFE
Advanced Skin Care Solutions
510(k) Summary of Safety and Effectiveness
ANSWER2SKIN™ SUNBURN RELIEF Cream ANSWER2SKIN™ FIRST AID Cream
Manufacturer and Submitter
| Company Name: | Dermal Life LLC |
|---|---|
| Company Address: | 13046 Race Track Rd. |
| Tampa, FL 33636 | |
| Contact Person: | William R. Hitchens |
| Date Summary Prepared: | August 24, 2012 |
| Telephone: 317.669.2229 |
Device
Trade/Device Name: Common/Usual Name: Classification Name: Regulation Number: Product Code: Classification Panel: Classification:
Dressing, Wound, Drug Wound Dressing Containing Drug Unclassified Unclassified FRO General & Plastic Surgery Unclassified
Substantial Equivalence
This 510(k) submission demonstrates that ANSWER2SKIN™ SUNBURN RELIEF Cream, and ANSWER2SKIN™ FIRST AID Cream are substantially equivalent to BIAFINE™ Wound Dressing Emulsion (K964240) in both technology and intended use.
Device Description
ANSWER2SKIN™ SUNBURN RELIEF Cream, and ANSWER2SKIN™ FIRST AID Cream are topical emulsions consisting of approximately 75% purified water, 20% wax (oily) ingredients, and 5% of dissolved ingredients such as triethanolamine sodium alginate, which forms a gel with water. ANSWER2SKIN™ SUNBURN RELIEF Cream, and ANSWER2SKIN™ FIRST AID Cream are over-the-counter products.
Indications for Use
ANSWER2SKIN™ SUNBURN RELIEF Cream is intended to be used Over-the-Counter as a wound dressing for the following indications: minor burns, including minor sunburns.
ANSWER2SKIN™ FIRST AID Cream is intended to be used Over-the-Counter as a wound dressing for the following indications: minor superficial wounds and minor abrasions, including cuts and scrapes.
3
Image /page/3/Picture/0 description: The image shows the text "K122595" at the top. Below that is the logo for "DERMAL LIFE Advanced Skin Care Solutions". The logo includes a stylized plus sign to the left of the text.
Summary of Technological Characteristics of the Device Compared to Predicate Device
ANSWER2SKIN™ SUNBURN RELIEF Cream, and ANSWER2SKIN™ FIRST AID Cream are technologically similar to one another and also to the predicate device. The Dermal Life products were tested for performance criteria (physical parameters, biocompatibility, human dermal studies for irritation and dermal sensitization). Performance data support that the Dermal Life wound dressings meet its specified criteria.
Conclusion
Functional and performance testing has been conducted to assess the safety and efficacy of ANSWER2SKIN™ SUNBURN RELIEF Cream, and ANSWER2SKIN™ FIRST AID Cream and the results support the substantial cquivalence to the predicate device.
,
4
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of an eagle with its wings spread, symbolizing the department's mission to protect the health of all Americans.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
Dermal Life LLC % Diane Horwitz, Ph.D., RAC Mandell Horwitz Consultants LLC 2995 Steven Martin Drive Fairfax, Virginia 22031
Re: K122595
Device Name: Hydropermeate Topical Emulsion, Answer2skin Sunburn Relief Cream and Answer2Skin First Aid Cream Regulation Name: Wound Dressing with Drug Regulatory Class: Unclassified Product Code: FRO Dated: March 14, 2013 Received: March 15, 2013
Dear Dr. Horwitz:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21
May 1, 2013
5
Page 2 - Diane Horwitz, Ph.D., RAC
CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Peter D厚Ruimm -S
Mark N. Melkerson Acting Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
Indications for Use
510(k) Number: K122595
Device Name: HYDROPERMEATE™ Topical Emulsion
Indications For Use:
HYDROPERMEATE™ Topical Emulsion is intended to be used as a wound dressing for the following indications:
- 트 Full thickness wounds, pressure sores, dermal ulcers including lower leg ulcers
- 트 Superficial wounds
- I 1st and 2nd degree burns, including sunburns
- 트 Dermal donor and graft site management
- 제 Radiation dermatitis
- 에 Minor abrasions
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________ (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Jiyoung Dang -S
(Division Sign-Off) Division of Surgical Devices 510(k) Number: K122595
7
Indications for Use
510(k) Number: K122595
ANSWER2SKIN™ SUNBURN RELIEF Cream and Device Name: ANSWER2SKIN™ FIRST AID Cream
Indications For Use:
ANSWER2SKIN™ SUNBURN RELIEF Cream is intended to be used Over-the-Counter as a wound dressing for the following indications: minor burns, including minor sunbums.
ANSWER2SKIN™ FIRST AID Cream is intended to be used Over-the-Counter as a wound dressing for the following indications: minor superficial wounds and minor abrasions, including cuts and scrapes.
Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use _ X (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Jiyoung Dang -S
(Division Sign-Off). Division of Surgical Devices 510(k) Number: K122595